Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology

Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology

ABSTRACT Scleroderma is an autoimmune disease that affects multiple systems. While pathophysiologic mechanisms governing the development of scleroderma are relatively poorly understood, advances in our understanding of the complement system are clarifying the role of complement pathways in the devel...

Full description

Bibliographic Details
Main Authors:	Roman Zuckerman, Arif Asif, Eric J. Costanzo, Tushar Vachharajani
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Nefrologia 2018-05-01
Series:	Brazilian Journal of Nephrology
Subjects:	Complement Activation Scleroderma, Systemic Acute Kidney Injury
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018005008102&lng=en&tlng=en

Similar Items

Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis
by: Ney Arencibia Pérez, et al.
Published: (2019-02-01)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
by: Palma LMP, et al.
Published: (2016-04-01)

Atypical hemolytic uremic syndrome
by: Yoko Yoshida, et al.
Published: (2017-04-01)

Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in China
by: Ze-Jia Sun, et al.
Published: (2016-01-01)

Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01)

C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction
by: Ravneet Bajwa, et al.
Published: (2018-02-01)

Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations
by: Mohammad A Hossain, et al.
Published: (2018-01-01)

Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome
by: Hong Jiang, et al.
Published: (2016-12-01)

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults
by: Thomas Barbour, et al.
Published: (2021-06-01)

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
by: Simona Buelli, et al.
Published: (2019-01-01)

Unraveling the complex genetics of atypical hemolytic uremic syndrome
by: Maga, Tara Kristen
Published: (2012)

Atypical hemolytic uremic syndrome triggered by varicella infection
by: Pauline Condom, et al.
Published: (2017-01-01)

Patient with ankylosing spondylitis and scleroderma renal crisis
by: Aliki I. Venetsanopoulou, et al.
Published: (2018-01-01)

Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease
by: E. I. Prokopenko, et al.
Published: (2020-07-01)

Scleroderma renal crisis: pathogenesis issues, disease pattern and modern approaches to the treatment
by: I.Yu. Golovach, et al.
Published: (2018-10-01)

Novel variation in CFB adult onset atypical hemolytic uremic syndrome: A case report and review
by: Malsawmkima Chhakchhuak, et al.
Published: (2020-01-01)

Atypical hemolytic uremic syndrome
by: Frémeaux-Bacchi Véronique, et al.
Published: (2011-09-01)

Juvenile Localized Scleroderma: A Very Rare Case
by: Nibedita Paul, et al.
Published: (2015-07-01)

The experience of using the Russian biosimilar of the original drug eculizumab for the treatment of patients with atypical hemolytic-uremic syndrome
by: Yulia V. Lavrishcheva, et al.
Published: (2020-07-01)

Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome
by: Hajeong Lee, et al.
Published: (2020-01-01)

A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
by: Shirley Pollack, et al.
Published: (2021-06-01)

Crise renal como manifestação inicial de esclerose sistêmica sine scleroderma Renal crisis as the initial clinical manifestation in systemic sclerosis sine scleroderma
by: Simone Appenzeller, et al.
Published: (2004-02-01)

Acquired Strabismus in Linear Scleroderma of the Face
by: Giorgia Martini, et al.
Published: (2019-06-01)

PARANEOPLASTIC SCLERODERMA OR NEOPLASIA SECONDARY TO SCLERODERMA
by: Alexandru Arvunescu, et al.
Published: (2019-12-01)

Norovirus: a novel etiologic agent in hemolytic uremic syndrome in an infant
by: Ghadi Abu Daher, et al.
Published: (2019-07-01)

Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease
by: Ramy M. Hanna, et al.
Published: (2019-09-01)

Challenges in classification of novel CFH variants in patients with atypical hemolytic uremic syndrome
by: Meera Sridharan, et al.
Published: (2020-12-01)

Outcome of psoriasis vulgaris on a child with localized scleroderma
by: Mariem Mohamed, et al.
Published: (2017-10-01)

Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma
by: Juliette Hardy, et al.
Published: (2019-03-01)

The manifestation’s feature of atypical hemolytic uremic syndrome using eculizumab (clinical case)
by: N.N. Guranova, et al.
Published: (2021-09-01)

Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis
by: Sigridur Sunna Aradottir, et al.
Published: (2021-06-01)

Characterization of the complement hereditary and acquired abnormalities in atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
by: Marinozzi, Maria Chiara
Published: (2016)

Exploring the genetics of a complex disease - atypical hemolytic uremic syndrome
by: Bu, Fengxiao
Published: (2016)

SCLERODERMA-LIKE MASK OF OSTEOPOIKILIA
by: R G Mukhina, et al.
Published: (2002-04-01)

End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012
by: Donal J. Sexton, et al.
Published: (2018-01-01)

Complement evaluation in atypical hemolytic uremic syndrome: Current concepts
by: Sidharth Kumar Sethi, et al.
Published: (2012-01-01)

Postoperative atypical hemolytic uremic syndrome in nontransplant setting: A case report with review of literature
by: Anil Khetarpal, et al.
Published: (2018-01-01)

Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome – description of two cases
by: Magdalena Marek, et al.
Published: (2016-06-01)

Esophagectomy in Scleroderma: Report of a Case
by: Erdal Yekeler, et al.
Published: (2008-12-01)

Systemic sclerosis medications and risk of scleroderma renal crisis
by: S. M. Gordon, et al.
Published: (2019-07-01)